Consistently, the protein levels of NONO were upregulated in resistant AML cells, indicating that NONO may be responsible for the increased SAMHD1 protein level and subsequent Ara-C resistance in resistant AML cells. This evidence concerns the gene SAMHD1 and acute myeloid leukemia.